期刊
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
卷 119, 期 4, 页码 179-187出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/13813455.2013.798334
关键词
Cardiac stem cells; cardiac progenitor cells; diabetic cardiomyopathy; free fatty acids; hyperglycaemia; miRNA; preservation
资金
- Fondazione Eli Lilly Italia
Diabetic cardiomyopathy consists of a series of structural and functional changes. Accumulating evidence supports the concept that a cardiac stem cell compartment disease plays an important role in the pathophysiology of diabetic cardiomyopathy. In diabetic hearts, human cardiac stem/progenitor cells (CSPC) are reduced and manifest defective proliferative capacity. Hyperglycaemia, hyperlipidemia, inflammation, and the consequent oxidative stress are enhanced in diabetes: these conditions can induce defects in both growth and survival of these cells with an imbalance between cell death and cell replacement, thus favouring the onset of diabetic cardiomyopathy and its progression towards heart failure. The preservation of CSPC compartment can contribute to counteract the negative impact of diabetes on the myocardium. The recent studies summarized in this review have improved our understanding of the development and stem cell biology within the cardiovascular system. However, several issues remain unsolved before cell therapy can become a clinical therapeutically relevant strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据